Skip to main content
PLOS One logoLink to PLOS One
. 2025 Nov 20;20(11):e0336403. doi: 10.1371/journal.pone.0336403

Associations of perceived neighborhood factors and Alzheimer’s disease polygenic score with cognition: Evidence from the Health and Retirement Study

Erin B Ware 1,2,*,#, Peiyao Zhu 3, Grace Noppert 1, Mingzhou Fu 3, Mikayla Benbow 3, Lindsay C Kobayashi 1,3, Lindsay H Ryan 1, Kelly M Bakulski 3
Editor: Mu-Hong Chen4
PMCID: PMC12633890  PMID: 41264616

Abstract

Background

We examined the relationships between neighborhood characteristics, cumulative genetic risk for Alzheimer’s disease (polygenic scores for Alzheimer’s disease), and cognitive function using data from the Health and Retirement Study (2008–2020, age > 50).

Methods

Baseline perceived neighborhood characteristics were combined into a subjective neighborhood disadvantage index. Cognitive function was assessed at baseline and measured biennially over a 10-year follow-up period. Analyses were stratified by genetic ancestry. Cox proportional hazard models analyzed associations between neighborhood characteristics, Alzheimer’s disease polygenic scores, and their interactions on cognitive impairment.

Results

In the European ancestries sample, a one standard deviation higher score on the subjective neighborhood disadvantage index was associated with a higher hazard of any cognitive impairment (HR:1.09; CI:1.03–1.15), cognitive impairment without dementia (HR:1.08; CI:1.03–1.14), and dementia (HR:1.13; CI:1.03–1.24). Similarly, a one standard deviation increase in Alzheimer’s disease polygenic score was associated with a higher risk of cognitive impairment (HR:1.10; CI:1.05–1.16) and cognitive impairment without dementia (HR:1.10; CI:1.05–1.16) but not dementia (HR:1.05; CI:0.96–1.16). No significant interactions were found. Evidence in African ancestries were directionally similar but imprecise and inconclusive due to limited precision and cross-ancestry polygenic score transferability. Subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score were independently associated with incident cognitive impairment.

Conclusions

Preventing dementia by addressing modifiable risk factors is essential.

Introduction

Dementia describes a group of progressive neurological disorders that severely affect individuals’ memory, thinking, and social abilities [1]. The most common type of dementia is Alzheimer’s disease, with pathology present in 60–80% of cases [2]. By the year 2050, an estimated 12.7 million Americans aged 65 years and older will be living with Alzheimer’s disease [3]. In 2022, the estimated medical cost associated with Alzheimer’s disease or other dementias amounted to $321 billion in the United States, with spending expected to exceed $1 trillion in 2050 [4], leading to a significant financial burden at both the family and national levels. Cognitive impairment non-dementia (CIND) is an intermediate stage between normal cognition and dementia [57]. Identifying modifiable risk factors for cognitive impairment is critical because addressing these factors during intermediate stages of cognitive decline can enhance the effectiveness of public health interventions, potentially reducing the progression to dementia and its related societal burden. In addition, understanding how these factors interact with individual susceptibilities can provide deeper insight into the pathways influencing cognitive decline and help inform strategies to reduce risk across diverse populations.

The neighborhood environment is a potential modifiable risk factor for cognitive health. Evidence suggests that neighborhood environment has been linked to risk of cognitive impairment and dementia [8,9], with both objective and subjective assessments of neighborhoods offering distinct insights into the association between neighborhoods and cognition [10]. Objective characteristics of neighborhoods, such as crime rates, access to amenities and neighborhood socioeconomic status, are often used to assess both neighborhood quality and the accessibly of resources in public health studies [10,11]. For example, in the French Three City Cohort, a population-based prospective study, women who lived in a deprived neighborhood—defined as having a low median income—had an increased risk of developing dementia and Alzheimer’s disease relative to those living in non-deprived neighborhoods [8]. In a cross-sectional study of 21,008 adults aged 65 years and older from Hong Kong, more walkable neighborhoods, measured by proximity to frequently-used amenities, were associated with 3.5% lower prevalence of dementia relative to the least walkable neighborhoods [12]. Subjective characteristics of neighborhoods—residents’ perceptions of their neighborhood environment—can be equally or more important in determining health outcome, as they directly reflect the mental and emotional responses to the environment which are not always captured by objective measures [10,13,14]. Feelings of safety, cleanliness, and social support can influence leisure-time physical activity and chronic stress [15,16]. A sense of neighborhood belonging, and the friendliness of neighbors can influence social connectedness and feelings of loneliness [17,18]. These factors collectively contribute to social engagement and overall mental health and are critical in maintaining cognitive function [1921].

Genetics also play a major role in the risk of developing cognitive impairment and dementia [22,23]. Variation in the Apolipoprotein E (APOE) gene is a major genetic risk factor for Alzheimer’s disease [24]. There are three major gene variants of the APOE gene, the ε2, ε3, and ε4 alleles [24]. At later ages, those with one copy of the APOE-ε4 allele have approximately three times increased risk of Alzheimer’s disease, and those with two copies of ε4 have 8–14 times increased risk, compared to the ε3/ε3 genotype [22]. However, genetics alone are neither sufficient nor necessary to cause dementia and it is important to understand the interplay between genetics and other factors on the risk of developing cognitive impairment.

Both genetic and environmental factors together contribute to the risk of cognitive impairment [25]. Gene-by-environment interactions occur when the effect of an environment is dependent on the genotype of the individual [26]. For example, in a longitudinal study of primary care patients aged 75 years or older, those with both the APOE-ε4 allele and low physical activity (defined as less than one physical activity per week) had a higher conversion rate (21.5%) to dementia and Alzheimer’s disease, as well as a higher relative risk (relative risk: 3.02, 95% CI: 2.07, 4.42) of dementia and Alzheimer’s disease, compared to those who had only one of the risk factors present [27]. Investigating gene-by-environment interactions, involving neighborhoods and genetic risk factors for dementia, enhances our understanding of the manifestation of diseases and significantly impact precision medicine by enabling targeted risk prevention for individuals highly susceptible to specific environmental effects [28,29].

In this study, we conducted a Cox proportional hazards analysis using data from participants of European and African genetic ancestries in the United States Health and Retirement Study. Our goal was to examine the associations between perceived neighborhood characteristics and incident cognitive impairment. We categorized cognitive impairment as 1) any cognitive impairment (CIND or dementia), 2) CIND, or 3) dementia. We stratified analyses by genetic ancestry group since the polygenic scores are on different scales due to the genetic architecture of the samples. Additionally, we assessed whether the association between perceived neighborhood characteristics and cognitive impairment was modified by Alzheimer’s disease polygenic score.

Methods

Health and Retirement Study

The Health and Retirement Study is a nationally representative, longitudinal panel study of people in the United States 50 years and older [30,31]. The Health and Retirement Study is funded by the National Institute on Aging (NIA U01AG009740) and the Social Security Administration. The Institute for Social Research at the University of Michigan conducts the Health and Retirement study. Data are collected through in-person and telephone interviews in waves occurring every two years since the study’s start in 1992. To maintain its nationally representative status, the sample of participants is replenished every six years with new cohorts. Data were accessed between 1 October 2017 and 1 June 2025 for research purposes. The authors had no access to information that could identify individual participants during or after data collection.

Neighborhood measures

Half of the Health and Retirement Study participants in 2008 were randomly selected to answer questions on their neighborhoods, while the other half were asked these questions during the 2010 wave [31]. In our analysis, we established a baseline for participants based in the wave in which they were interviewed for the neighborhood questions (either 2008 or 2010). Participants were asked to rate aspects of their neighborhood as a part of a leave-behind questionnaire. Neighborhoods were defined as a participant’s ‘local area’ or everywhere ‘within a 20-minute walk or about a mile of their house.’ Participant-evaluated neighborhood characteristics include: 1) There is no problem with vandalism and graffiti in this area/Vandalism and graffiti are a big problem in this area, 2) Most people in this area can be trusted/Most people in this area can’t be trusted, 3) People feel safe walking alone in this area after dark/People would be afraid to walk alone in this area after dark, 4) Most people in this area are friendly/Most people in this area are unfriendly, 5) This area is kept very clean/This area is always full of rubbish and litter, 6) There are no vacant houses or storefronts in this area/There are many vacant or deserted houses or storefronts in this area. 7) People feel that they are part of/don’t belong in this area. Participants were instructed to choose a value of one to seven for each of the questions, with one corresponding to the first response scale and seven corresponding to the latter response scale of each question. The responses to each neighborhood question were standardized (mean = 0, standard deviation = 1). Given correlations among responses to these seven questions, we created a subjective neighborhood disadvantage index using principal components analysis to identify factors representing the most variation in the neighborhood question responses [32]. Higher subjective neighborhood disadvantage indexes indicate more disadvantaged neighborhoods. Secondary analyses considered a dichotomous version of the subjective neighborhood disadvantage index, with scores of 0 or below indicating the least disadvantaged neighborhoods and scores above 0 indicating the most disadvantaged neighborhoods. Additionally, we conducted supplemental analyses using each neighborhood characteristic as a separate exposure.

Cognitive status

The Health and Retirement Study collects information on participants’ cognition in every data collection wave. We assessed participants’ cognitive function at baseline and followed up with up to five waves of cognitive assessments over the subsequent ten years, from 2010 to 2018 for those with a 2008 baseline, and from 2012 to 2020 for those with a 2010 baseline. The Health and Retirement Study cognitive assessments include ten word immediate and delayed recall, serial 7s subtraction, counting backwards, object naming and recall of date and president and vice-president. These tests assess memory, working memory, attention and processing speed, language, and orientation and are administered via telephone [33].

We used the Health and Retirement Study Imputation of Cognitive Functioning Measures data which provides cleaned and imputed cognitive function assessment scores [34]. Proxy respondents were excluded from our study sample at each wave. To categorize cognitive status in the Health and Retirement Study, we used the Langa-Weir approach, which uses a composite score of 0–27 from the cognitive assessments available in the Health and Retirement Study (excluding orientation and naming objects). Individuals with scores from 0–6 were categorized as having dementia, 7–11 as CIND, and 12–27 as normal cognition [35].

Polygenic score for Alzheimer’s disease

The Health and Retirement Study collected saliva samples in 2006, 2008, 2010, or 2012 for DNA processing. In 2006, the mouthwash collection method was used, then from 2008 on, the Oragene DNA Collection Kit (OG250) was used. Approximately 2.4 million single nucleotide polymorphisms (SNPs) were measured using the Ilumina HumanOmni2.5 BeadChip array (HumanOmni2.5-4v1, HumanOmni2.5-8v1). The University of Washington Genetics Coordinating Center performed genotyping quality control. SNPs were aligned to genome build 37/hg 19, phased using SHAPEIT2, and genetic principal components were calculated with HapMap controls [36,37]. Imputation was conducted by the University of Washington Genetics Coordinating Center using IMPUTE2, to impute approximately 21 million SNPs to the 1000 Genomes Project cosmopolitan reference panel phase 3 version 5 [38]. Genetic data for the Health and Retirement Study is available through application to the National Institute on Aging Genetics of Alzheimer’s Disease Data Storage Site (https://dss.niagads.org/datasets/ng00153/).

The Health and Retirement Study used both self-identified race/ethnicity and ancestral genetic similarity to ascertain the African and European ancestries analytic samples. To account for population stratification within the two broad ancestries groups, local genetic principal components were calculated within each group and used in downstream analyses, provided by the Health and Retirement Study [38,39].

A polygenic score provides a quantitative summary measure of the genetic predisposition to express a the given trait [40]. The Health and Retirement Study provides polygenic scores from the International Genomics of Alzheimer’s Project (IGAP) using SNPs associated with Alzheimer’s disease at two genome-wide association p-value thresholds (pT): pT = 0.01 and pT = 1.0 [41]. In this study, we used a p-value threshold of pT = 0.01 and did not include linkage disequilibrium in the scores (i.e., no pruning algorithms). The APOE gene region (start: 43.38 megabases, stop: 45.43 megabases, build hg37) was removed from the polygenetic score because including it through weighted variants was insufficient to capture the substantial risk attributed to this region [42]. Therefore, we treated the APOE region as a separate covariate to better account for its independent effect on dementia risk. Our primary analysis used z-score standardized polygenic scores (mean = 0, standard deviation = 1) within each genetic ancestry group. In subsequent analyses, we dichotomized the polygenic score for Alzheimer’s disease without the APOE region at the 75th percentile to represent those in the highest quartile of genetic risk for Alzheimer’s disease [43].

Covariate measures

We selected covariates that could be confounders of the association between neighborhood characteristics and cognitive status, based on prior evidence [44,45]. Covariates were assessed at the analytical baseline (2008 or 2010) and were: age (continuous, in years), sex (male; female) highest educational attainment (above high school/GED; high school/GED; less than high school/GED), subjective social status (self-reported standing on a ladder representing “society”, continuous range 1 [low] to 10 [high]) [46], and poverty status, defined as whether household income was below the US Census poverty threshold (yes; no). Additionally, we included an indicator variable for baseline wave (wave 2008; wave 2010) to account for potential cohort differences.

In sensitivity analyses, we considered the additional potential confounders of smoking (current, former, never), alcohol consumption (number of drinks/day when drinks), history of type 2 diabetes (yes, no), depressive symptoms (continuous), body mass index (BMI; continuous, in kg/m2), self-rated hearing (excellent, very good, good, fair, poor), self-rated vision (excellent, very good, good, fair, poor, blind), brain-related conditions (yes, no to a report of stroke and/or psychiatric problems) and number of physician-diagnosed chronic medical conditions (0, 1–2, 3 or more of the following: high blood pressure, diabetes, cancer, lung disease, heart disease, and arthritis), all measured at the analytical baseline (2008 or 2010). We considered these covariates in a sensitivity analysis rather than the main analysis, as although they have been associated with cognitive status [4750], they are time-varying and could be influenced by neighborhood factors. Therefore, these variables may lie on the causal pathway rather than serve as confounders.

Sample selection

Eligible Health and Retirement Study participants were those who were interviewed in the 2008 and 2010 waves with complete neighborhood data (n = 14,562). Then, we excluded participants with incomplete genetic (n = 5,220), cognition (n = 717), and covariate data (n = 717) (Fig 1 and S1 Table). Additionally, we excluded participants with dementia at baseline (N = 148) from analyses where dementia was the outcome. For analyses of any cognitive impairment (CIND and dementia), participants with CIND and dementia at baseline (N = 1,082) were excluded. In CIND-specific analyses, we further excluded participants who developed dementia during follow-up without prior records of CIND (N = 80) (Fig 1 and S1 Table).

Fig 1. Sample inclusion and exclusion flow chart for the Health and Retirement Study 2018 and 2010 wave.

Fig 1

Statistical analysis

All the analyses were stratified by genetic ancestry (European ancestries and African ancestries). In bivariate analyses, we described the distributions of variables by cognitive functions using t-test (mean, SD) for continuous variables and chi-square test (count, %) for categorical variables. We similarly tested for differences between the included and excluded sample to note selection bias in the included sample.

We used Cox proportional hazard modeling to examine the associations between the subjective neighborhood disadvantage index and incident cognitive impairment, with effect modification by Alzheimer’s disease polygenic score. In model 1, we include adjustments for sociodemographic factors (baseline age, sex, education, poverty status, subjective social status), APOE-ε4 carrier status, and baseline year indicator. Model 2 included additional adjustment for Alzheimer’s disease polygenic score and genetic principal components. Model 3 further tested the interaction between the subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score. The subjective neighborhood disadvantage index, covariates, and supplementary variables were measured at baseline, with cognitive function assessed at baseline and across five follow-up waves over 10 years.

The following fully adjusted model was fitted to our dataset:

λ(t|X)=λ0(t)exp(β1Neighborhood+β2PGS_AD+ β3(Neighborhood×PGS_AD)+β4Covariates) (1)

where λ(t|X) is the hazard function at time t given covariates X, and λ0(t)is the baseline hazard at time t. We performed three separate comparisons using this model specification stratified by ancestries: 1) any incident cognitive impairment (CIND or dementia) as the outcome compared to normal cognition, 2) incident CIND as the outcome compared to normal cognition and 3) incident dementia as the outcome compared to no dementia, where “no dementia” includes both normal cognition and CIND. This approach maintains sample size by keeping individuals who developed CIND during follow-up, who have a higher risk of progressing to dementia, in the reference group until dementia onset. We considered P values <0.05 as indicating statistical significance.

We conducted analyses in SAS (9.4 version) and R statistical software (4.3.3 version).

Relative excess risk due to interaction

Additive interaction, a more relevant public health measure than multiplicative interaction, is often emphasized in epidemiology because it reflects the absolute difference in risk associated with combined exposures [51,52]. Therefore, we calculated both multiplicative and additive interaction in the study. To assess additive interaction, we evaluated Cox proportional hazard models using dichotomized subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score. We then calculated relative excess risk due to interaction (RERI), to further elucidate the additive interaction between subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score on cognitive impairment, due to its outstanding performance in Cox proportional hazard models [53]. The RERI was calculated using the “epiR” package [54] in R statistical software (4.3.3 version). A positive RERI indicates a positive interaction or more than additivity, zero indicates no interaction, and a negative value indicates negative interaction or less than additivity [55].

Sensitivity analysis

In our first sensitivity models, we included a third set of variables as covariates—smoking status, alcohol consumption, BMI, diabetes, self-rated hearing, self-rated vision, brain-related conditions, number of chronic conditions, and depression—which are time-varying factors that may lie on the causal pathway rather than act as confounders. Additionally, to determine if any individual neighborhood factor (perceived safety, trust, friendly, cleanness, vandalism, vacant, belonging—each represented by one of the seven questions in the neighborhood measures) drives the observed associations, we evaluated each individual neighborhood factor as exposures in modeling.

Ethics

This secondary analysis was approved by the University of Michigan Institutional Review Board (HUM00128220). Participants provided written informed consent. Research practices at the University of Michigan are guided by the ethical principles outlined in the Belmont Report, which include respect for persons, beneficence, and justice.

Results

Descriptive analysis

In our study sample, participants who developed cognitive impairment tended to be older, female, have higher subjective neighborhood disadvantage indexes (indicating lower perceived safety, friendliness and environment), more likely to have lower education levels, and reported lower subjective social status (Table 1). The sample distribution, stratified by genetic ancestries, included 703 participants of African ancestries and 6,123 of European ancestries (N = 6,826) for cognitive impairment sample; 695 of African ancestries and 6,051 of European ancestries (N = 6,746) for CIND sample; and 971 of African ancestries and 6,789 of European ancestries (N = 7,760) for dementia sample (Fig 1 and S2 Table). Additionally, individuals’ responses to the seven neighborhood characteristics were correlated (Fig 2).

Table 1. Sample distribution of neighborhood disadvantage index, cognitive function, genetic characteristics, sociodemographic, behavioral, and chronic conditions by cognitive impairment (CIND and dementia), CIND, and dementia in the Health and Retirement Study, wave 2008-2010.

Main Variables Cognitive Impairmentc CINDc Dementiac
Overalla Normala Cognitive Impairmenta p-valueb Overalla Normala CINDa p-valueb Overalla Non-dementiaa Dementiaa p-valueb
N = 6,826 N = 4,754 N = 2,072 N = 6,746 N = 4,754 N = 1,992 N = 7,760 N = 7,142 N = 618
Neighborhood disadvantage index −0.13 (0.90) −0.16 (0.86) −0.05 (0.97) <0.001 −0.13 (0.90) −0.16 (0.86) −0.06 (0.97) <0.001 −0.10 (0.93) −0.11 (0.92) 0.05 (1.03) <0.001
Neighborhood disadvantage index (Binary) <0.001 <0.001 <0.001
 The least disadvantaged neighborhoods (<=0) 4,537 (66%) 3,234 (68%) 1,303 (63%) 4,488 (67%) 3,234 (68%) 1,254 (63%) 5,070 (65%) 4,716 (66%) 354 (57%)
 The most disadvantaged neighborhoods (>0) 2,289 (34%) 1,520 (32%) 769 (37%) 2,258 (33%) 1,520 (32%) 738 (37%) 2,690 (35%) 2,426 (34%) 264 (43%)
Baseline wave <0.001 <0.001 <0.001
 Wave 1 (2008) 3,008 (44%) 2,023 (43%) 985 (48%) 2,971 (44%) 2,023 (43%) 948 (48%) 3,436 (44%) 3,120 (44%) 316 (51%)
 Wave 2 (2010) 3,818 (56%) 2,731 (57%) 1,087 (52%) 3,775 (56%) 2,731 (57%) 1,044 (52%) 4,324 (56%) 4,022 (56%) 302 (49%)
Ancestry <0.001 <0.001 <0.001
 European ancestry 6,123 (90%) 4,356 (92%) 1,767 (85%) 6,051 (90%) 4,356 (92%) 1,695 (85%) 6,789 (87%) 6,337 (89%) 452 (73%)
 African ancestry 703 (10%) 398 (8.4%) 305 (15%) 695 (10%) 398 (8.4%) 297 (15%) 971 (13%) 805 (11%) 166 (27%)
PGS-AD
 European ancestry −0.08 (0.98) −0.12 (0.98) 0.00 (0.96) −0.09 (0.98) −0.12 (0.98) −0.01 (0.96) −0.08 (0.98) −0.08 (0.98) −0.05 (0.94)
 African ancestry 0.06 (0.93) −0.04 (0.94) 0.19 (0.90) 0.06 (0.93) −0.04 (0.94) 0.18 (0.90) 0.06 (0.91) 0.05 (0.92) 0.10 (0.83)
PGS-AD (Binary)
 European ancestry
  Below 75% 4,769 (78%) 3,429 (79%) 1,340 (76%) 4,719 (78%) 3,429 (79%) 1,290 (76%) 5,267 (78%) 4,930 (78%) 337 (75%)
  Above 75% 1,354 (22%) 927 (21%) 427 (24%) 1,332 (22%) 927 (21%) 405 (24%) 1,522 (22%) 1,407 (22%) 115 (25%)
 African ancestry
  Below 75% 534 (76%) 315 (79%) 219 (72%) 531 (76%) 315 (79%) 216 (73%) 741 (76%) 613 (76%) 128 (77%)
  Above 75% 169 (24%) 83 (21%) 86 (28%) 164 (24%) 83 (21%) 81 (27%) 230 (24%) 192 (24%) 38 (23%)
APOE E4 status <0.001 <0.001 <0.001
 Any copies of e4 1,807 (26%) 1,200 (25%) 607 (29%) 1,783 (26%) 1,200 (25%) 583 (29%) 2,094 (27%) 1,860 (26%) 234 (38%)
 No copies of e4 5,019 (74%) 3,554 (75%) 1,465 (71%) 4,963 (74%) 3,554 (75%) 1,409 (71%) 5,666 (73%) 5,282 (74%) 384 (62%)
Sex 0.015 0.018 0.476
 Male 2,674 (39%) 1,818 (38%) 856 (41%) 2,641 (39%) 1,818 (38%) 823 (41%) 3,093 (40%) 2,855 (40%) 238 (39%)
 Female 4,152 (61%) 2,936 (62%) 1,216 (59%) 4,105 (61%) 2,936 (62%) 1,169 (59%) 4,667 (60%) 4,287 (60%) 380 (61%)
Age 66.61 (10.06) 64.74 (9.54) 70.91 (9.90) <0.001 66.54 (10.04) 64.74 (9.54) 70.83 (9.88) <0.001 67.29 (10.28) 66.68 (10.09) 74.34 (9.76) <0.001
Education Level <0.001 <0.001 <0.001
  > High School/ GED 2,362 (35%) 1,888 (40%) 474 (23%) 2,336 (35%) 1,888 (40%) 448 (22%) 2,489 (32%) 2,394 (34%) 95 (15%)
 High School/ GED 3,921 (57%) 2,643 (56%) 1,278 (62%) 3,876 (57%) 2,643 (56%) 1,233 (62%) 4,425 (57%) 4,103 (57%) 322 (52%)
  < High School/ GED 543 (8.0%) 223 (4.7%) 320 (15%) 534 (7.9%) 223 (4.7%) 311 (16%) 846 (11%) 645 (9.0%) 201 (33%)
Poverty Status <0.001 <0.001 <0.001
 Above Poverty threshold 6,518 (95%) 4,574 (96%) 1,944 (94%) 6,441 (95%) 4,574 (96%) 1,867 (94%) 7,320 (94%) 6,780 (95%) 540 (87%)
 Below Poverty threshold 308 (4.5%) 180 (3.8%) 128 (6.2%) 305 (4.5%) 180 (3.8%) 125 (6.3%) 440 (5.7%) 362 (5.1%) 78 (13%)
Social Ladder 6.55 (1.66) 6.63 (1.63) 6.36 (1.70) <0.001 6.55 (1.66) 6.63 (1.63) 6.35 (1.71) <0.001 6.51 (1.68) 6.52 (1.67) 6.37 (1.81) 0.049
Sensitivity Variables Overall* Normal CIND p-value Overall* Normal CIND p-value Overall* Non-dementia Dementia p-value
Smoking status 0.019 0.02 0.094
 Current Smoker 819 (12%) 569 (12%) 250 (12%) 813 (12%) 569 (12%) 244 (12%) 946 (12%) 883 (12%) 63 (10%)
 Former Smoker 2,917 (43%) 1,981 (42%) 936 (45%) 2,877 (43%) 1,981 (42%) 896 (45%) 3,358 (44%) 3,068 (43%) 290 (47%)
 Never Smoke 3,050 (45%) 2,178 (46%) 872 (42%) 3,018 (45%) 2,178 (46%) 840 (42%) 3,411 (44%) 3,150 (44%) 261 (43%)
BMI 28.67 (6.00) 28.74 (6.01) 28.50 (5.99) 0.136 28.68 (6.00) 28.74 (6.01) 28.55 (5.97) 0.248 28.60 (6.04) 28.69 (6.05) 27.66 (5.79) <0.001
Drinking (# drinks/day when drinks) 0.81 (1.37) 0.86 (1.35) 0.69 (1.41) <0.001 0.81 (1.37) 0.86 (1.35) 0.69 (1.42) <0.001 0.78 (1.38) 0.80 (1.38) 0.55 (1.42) <0.001
Ever have Diabetes <0.001 <0.001 0.037
 Yes 1,129 (17%) 711 (15%) 418 (20%) 1,119 (17%) 711 (15%) 408 (20%) 1,369 (18%) 1,241 (17%) 128 (21%)
 No 5,697 (83%) 4,043 (85%) 1,654 (80%) 5,627 (83%) 4,043 (85%) 1,584 (80%) 6,391 (82%) 5,901 (83%) 490 (79%)
Brain Condition <0.001 <0.001 <0.001
 No 5,516 (81%) 3,908 (82%) 1,608 (78%) 5,456 (81%) 3,908 (82%) 1,548 (78%) 6,211 (80%) 5,751 (81%) 460 (74%)
 Yes 1,310 (19%) 846 (18%) 464 (22%) 1,290 (19%) 846 (18%) 444 (22%) 1,549 (20%) 1,391 (19%) 158 (26%)
Chronic Condition <0.001 <0.001 <0.001
 None 1,194 (17%) 943 (20%) 251 (12%) 1,181 (18%) 943 (20%) 238 (12%) 1,303 (17%) 1,228 (17%) 75 (12%)
 1 - 2 3,899 (57%) 2,771 (58%) 1,128 (54%) 3,858 (57%) 2,771 (58%) 1,087 (55%) 4,349 (56%) 4,018 (56%) 331 (54%)
 >= 3 1,733 (25%) 1,040 (22%) 693 (33%) 1,707 (25%) 1,040 (22%) 667 (33%) 2,108 (27%) 1,896 (27%) 212 (34%)
Eyesight <0.001 <0.001 <0.001
 Excellent 729 (11%) 561 (12%) 168 (8.1%) 721 (11%) 561 (12%) 160 (8.0%) 793 (10%) 746 (10%) 47 (7.6%)
 Very Good 2,214 (32%) 1,661 (35%) 553 (27%) 2,191 (32%) 1,661 (35%) 530 (27%) 2,406 (31%) 2,279 (32%) 127 (21%)
 Good 2,886 (42%) 1,979 (42%) 907 (44%) 2,853 (42%) 1,979 (42%) 874 (44%) 3,295 (42%) 3,032 (42%) 263 (43%)
 Fair 793 (12%) 445 (9.4%) 348 (17%) 781 (12%) 445 (9.4%) 336 (17%) 983 (13%) 861 (12%) 122 (20%)
 Poor 193 (2.8%) 103 (2.2%) 90 (4.3%) 190 (2.8%) 103 (2.2%) 87 (4.4%) 268 (3.5%) 211 (3.0%) 57 (9.2%)
 Blind 8 (0.1%) 4 (<0.1%) 4 (0.2%) 7 (0.1%) 4 (<0.1%) 3 (0.2%) 12 (0.2%) 10 (0.1%) 2 (0.3%)
Hearing <0.001 <0.001 <0.001
 Excellent 1,278 (19%) 965 (20%) 313 (15%) 1,269 (19%) 965 (20%) 304 (15%) 1,419 (18%) 1,331 (19%) 88 (14%)
 Very Good 2,127 (31%) 1,603 (34%) 524 (25%) 2,105 (31%) 1,603 (34%) 502 (25%) 2,315 (30%) 2,177 (30%) 138 (22%)
 Good 2,251 (33%) 1,501 (32%) 750 (36%) 2,223 (33%) 1,501 (32%) 722 (36%) 2,596 (33%) 2,367 (33%) 229 (37%)
 Fair 911 (13%) 543 (11%) 368 (18%) 892 (13%) 543 (11%) 349 (18%) 1,098 (14%) 975 (14%) 123 (20%)
 Poor 257 (3.8%) 141 (3.0%) 116 (5.6%) 255 (3.8%) 141 (3.0%) 114 (5.7%) 330 (4.3%) 291 (4.1%) 39 (6.3%)
Depression 1.08 (1.71) 0.96 (1.62) 1.35 (1.86) <0.001 1.08 (1.71) 0.96 (1.62) 1.35 (1.88) <0.001 1.15 (1.76) 1.11 (1.74) 1.60 (1.94) <0.001

CIND: Cognitive impairment non-dementia, PGS-AD: Polygenic score – Alzheimer’s disease.

an (%); Mean (SD).

bPearson’s Chi-squared test; Welch Two Sample t-test.

cAverage follow-up duration: Cognitive Impairment = 7.41 years; Cognitive Impairment, No Dementia (CIND) = 7.45 years; Dementia = 8.02 years.

*Sample size after excluding all missing values, including sensitivity analysis covariates: for Cognitive Impairment analysis: 6,727, CIND: 6,650, Dementia: 7,645.

Fig 2. Correlations between neighborhood characteristics in the Health and Retirement Study 2018 and 2010 wave.

Fig 2

European ancestries sample

Multivariable analysis.

In the European ancestries sample, each standard deviation increase in the subjective neighborhood disadvantage index was associated with an 9% higher risk of developing any cognitive impairment (95% CI: 1.03, 1.15), an 8% higher risk of CIND (95% CI: 1.02–1.14), and a 13% higher risk of dementia (95% CI: 1.02–1.24) in the fully adjusted model (Model 3 in Table 2). In the fully adjusted models, each standard deviation increase in the Alzheimer’s disease polygenic score was associated with a 10% increased risk of any cognitive impairment and CIND (95% CI: 1.05–1.16). The Alzheimer’s disease polygenic score was not significantly associated with dementia. No significant multiplicative interaction was found between the subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score for any of the outcomes in the European ancestries sample (Table 2).

Table 2. Hazard Ratios from survival analysis stratified by Ancestry, estimates present the association for each standard deviation increase in the neighborhood disadvantage index with incident cognitive impairment (CIND and dementia), CIND, and dementia, relative to normal cognition and non-dementia respectively in the US Health and Retirement Study (2008-2010 Waves).
Cognitive Impairment vs. Normal Cognition, European Ancestryb (n = 6,123) CIND vs. Normal Cognition, European Ancestryb (n = 6,051) Dementia vs. Non-dementia, European Ancestryb (n = 6,789)
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value
Neighborhood 1.09 1.03, 1.15 0.002 1.09 1.03, 1.15 0.002 1.09 1.03, 1.15 0.002 1.08 1.03, 1.14 0.004 1.08 1.02, 1.14 0.004 1.08 1.02, 1.14 0.004 1.13 1.03, 1.24 0.010 1.13 1.02, 1.24 0.014 1.13 1.02, 1.24 0.015
Age 1.08 1.07, 1.08 <0.001 1.08 1.07, 1.08 <0.001 1.08 1.07, 1.08 <0.001 1.08 1.07, 1.08 <0.001 1.08 1.07, 1.08 <0.001 1.08 1.07, 1.08 <0.001 1.12 1.10, 1.13 <0.001 1.12 1.10, 1.13 <0.001 1.12 1.10, 1.13 <0.001
Sex
 Female Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Male 1.3 1.18, 1.43 <0.001 1.29 1.18, 1.42 <0.001 1.29 1.18, 1.42 <0.001 1.31 1.19, 1.45 <0.001 1.31 1.18, 1.44 <0.001 1.31 1.19, 1.44 <0.001 1.05 0.87, 1.28 0.600 1.06 0.87, 1.29 0.600 1.06 0.88, 1.29 0.500
Education
 Above High School/GED Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 High School/GED 1.62 1.44, 1.82 <0.001 1.62 1.44, 1.82 <0.001 1.62 1.44, 1.82 <0.001 1.65 1.46, 1.86 <0.001 1.65 1.46, 1.86 <0.001 1.65 1.46, 1.86 <0.001 1.58 1.23, 2.04 <0.001 1.6 1.24, 2.06 <0.001 1.59 1.23, 2.06 <0.001
 Less than High School/GED 3.03 2.56, 3.58 <0.001 3.03 2.56, 3.58 <0.001 3.02 2.56, 3.58 <0.001 3.08 2.60, 3.66 <0.001 3.08 2.60, 3.66 <0.001 3.08 2.59, 3.66 <0.001 3.93 2.92, 5.29 <0.001 3.98 2.95, 5.37 <0.001 3.98 2.95, 5.37 <0.001
Poverty Status (Below)
 Above Poverty threshold Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Below Poverty threshold 1.28 0.99, 1.65 0.055 1.27 0.99, 1.64 0.062 1.27 0.99, 1.64 0.062 1.28 0.99, 1.66 0.060 1.27 0.98, 1.65 0.068 1.27 0.98, 1.65 0.068 2.03 1.39, 2.98 <0.001 2.07 1.41, 3.04 <0.001 2.07 1.41, 3.04 <0.001
APOE E4 status
 No copies of e4 Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Any copies of e4 1.43 1.29, 1.59 <0.001 1.42 1.28, 1.57 <0.001 1.42 1.28, 1.57 <0.001 1.43 1.29, 1.60 <0.001 1.42 1.28, 1.58 <0.001 1.42 1.28, 1.58 <0.001 2.06 1.70, 2.50 <0.001 2.04 1.68, 2.48 <0.001 2.04 1.68, 2.48 <0.001
Social Ladder 0.93 0.90, 0.95 <0.001 0.93 0.90, 0.95 <0.001 0.93 0.90, 0.95 <0.001 0.92 0.89, 0.95 <0.001 0.92 0.90, 0.95 <0.001 0.92 0.89, 0.95 <0.001 0.98 0.92, 1.04 0.500 0.98 0.93, 1.04 0.600 0.98 0.93, 1.04 0.6
Baseline wave
 Wave 1 (2008) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Wave 2 (2010) 0.86 0.78, 0.94 0.001 0.86 0.79, 0.95 0.002 0.86 0.79, 0.95 0.002 0.86 0.78, 0.95 0.002 0.87 0.79, 0.95 0.003 0.86 0.79, 0.95 0.003 0.8 0.67, 0.97 0.022 0.8 0.67, 0.97 0.021 0.8 0.67, 0.97 0.020
PGS-AD 1.1 1.05, 1.16 <0.001 1.10 1.05, 1.16 <0.001 1.10 1.05, 1.16 <0.001 1.10 1.05, 1.16 <0.001 1.05 0.96, 1.16 0.300 1.05 0.95, 1.16 0.3
Neighborhood* PGS-AD 0.99 0.94, 1.04 0.800 0.99 0.94, 1.05 0.800 0.98 0.90, 1.08 0.7
RERI: The most disadvantaged neighborhoods*PGS-AD Above 75% a −0.02 −0.31, 0.27 −0.03 −0.32, 0.27 0.01 −0.61, 0.63
Cognitive Impairment vs. Normal Cognition, African Ancestryc (n = 703) CIND vs. Normal Cognition, African Ancestryc (n = 695) Dementia vs. Non-dementia, African Ancestryc (n = 971)
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value HR 95% CI p-value
Neighborhood 1.04 0.93, 1.16 0.500 1.04 0.93, 1.16 0.500 1.05 0.94, 1.17 0.4 1.04 0.93, 1.16 0.500 1.04 0.93, 1.16 0.500 1.04 0.93, 1.17 0.500 1.02 0.89, 1.18 0.800 1.03 0.89, 1.19 0.700 1.03 0.90, 1.20 0.6
Age 1.05 1.04, 1.07 <0.001 1.05 1.04, 1.07 <0.001 1.05 1.04, 1.07 <0.001 1.05 1.04, 1.07 <0.001 1.05 1.04, 1.07 <0.001 1.05 1.04, 1.07 <0.001 1.09 1.07, 1.11 <0.001 1.09 1.07, 1.11 <0.001 1.09 1.07, 1.11 <0.001
Sex
 Female Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Male 1.2 0.94, 1.53 0.150 1.22 0.95, 1.56 0.110 1.22 0.96, 1.56 0.11 1.19 0.93, 1.52 0.200 1.2 0.94, 1.54 0.200 1.2 0.94, 1.54 0.15 1.32 0.96, 1.82 0.088 1.37 0.99, 1.89 0.056 1.37 1.00, 1.89 0.053
Education
 Above High School/GED Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 High School/GED 1.5 1.11, 2.03 0.009 1.51 1.11, 2.04 0.009 1.51 1.11, 2.05 0.009 1.53 1.12, 2.09 0.007 1.54 1.12, 2.10 0.007 1.54 1.13, 2.11 0.007 2.14 1.15, 3.96 0.016 2.21 1.19, 4.10 0.012 2.21 1.19, 4.09 0.012
 Less than High School/GED 3.02 2.12, 4.31 <0.001 2.94 2.06, 4.20 <0.001 2.97 2.08, 4.25 <0.001 3.11 2.17, 4.46 <0.001 3 2.09, 4.30 <0.001 3.02 2.10, 4.34 <0.001 5.48 2.94, 10.2 <0.001 5.61 3.00, 10.5 <0.001 5.6 2.99, 10.5 <0.001
Poverty Status
 Above Poverty threshold Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Below Poverty threshold 1.78 1.34, 2.37 <0.001 1.81 1.36, 2.41 <0.001 1.82 1.36, 2.43 <0.001 1.79 1.34, 2.39 <0.001 1.81 1.36, 2.42 <0.001 1.83 1.37, 2.44 <0.001 1.86 1.30, 2.65 <0.001 1.83 1.28, 2.61 <0.001 1.82 1.28, 2.61 <0.001
APOE E4 status
 No copies of e4 Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Any copies of e4 1.01 0.80, 1.28 >0.9 1.02 0.80, 1.29 0.900 1 0.79, 1.28 >0.9 1 0.79, 1.27 >0.9 1.01 0.79, 1.28 >0.9 0.99 0.78, 1.26 >0.9 1.44 1.05, 1.96 0.024 1.46 1.06, 2.00 0.020 1.43 1.04, 1.97 0.026
Social Ladder 0.97 0.91, 1.03 0.300 0.96 0.90, 1.02 0.200 0.96 0.90, 1.02 0.2 0.97 0.91, 1.04 0.400 0.96 0.90, 1.03 0.300 0.96 0.90, 1.03 0.3 1.06 0.98, 1.16 0.200 1.06 0.97, 1.15 0.200 1.06 0.97, 1.15 0.2
Baseline wave
 Wave 1 (2008) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Wave 2 (2010) 1.19 0.94, 1.51 0.150 1.17 0.92, 1.48 0.200 1.17 0.92, 1.48 0.2 1.2 0.94, 1.52 0.150 1.17 0.92, 1.50 0.200 1.17 0.92, 1.50 0.2 1.12 0.82, 1.53 0.500 1.1 0.80, 1.50 0.600 1.11 0.81, 1.52 0.5
PGS-AD 1.13 0.95, 1.35 0.200 1.15 0.96, 1.38 0.12 1.11 0.93, 1.33 0.200 1.13 0.95, 1.35 0.2 1.09 0.86, 1.39 0.500 1.12 0.88, 1.44 0.4
Neighborhood* PGS-AD 0.94 0.82, 1.07 0.3 0.94 0.82, 1.08 0.4 0.92 0.78, 1.09 0.3
RERI: The most disadvantaged neighborhoods *PGS-AD Above 75% a −0.42 −1.09, 0.25 −0.33 −0.97, 0.31 −0.14 −0.96, 0.68

aRERI was calculated based on the model using a dichotomized neighborhood disadvantage index (≤ 0 indicating the least disadvantaged neighborhoods; > 0 indicating the most disadvantaged neighborhoods) and PGS-AD (cutoff at the 75th percentile). Full model details are provided in S3 Table.

bEuropean Ancestry Sample average follow-up duration: Cognitive Impairment = 7.49 years; Cognitive Impairment, No Dementia (CIND) = 7.53 years; Dementia = 8.04 years.

cAfrican Ancestry Sample average follow-up duration: Cognitive Impairment = 6.71 years; Cognitive Impairment, No Dementia (CIND) = 6.77 years; Dementia = 7.85 years.

RERI analysis.

In models using dichotomous exposures (subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score), individuals living in the more disadvantaged neighborhoods had a 21% higher risk of any cognitive impairment (95% CI: 1.08–1.36), a 20% higher risk of CIND (95% CI: 1.06–1.35), and a 34% higher risk of dementia (95% CI: 1.07–1.68) compared to those in the least disadvantaged neighborhoods (S3 Table). Participants with an Alzheimer’s disease polygenic score in the top 25% of the sample had a 12% higher risk of developing any cognitive impairment (95% CI: 1.01–1.25). However, no significant associations were observed between the dichotomous Alzheimer’s disease polygenic score and the risk of CIND (HR: 1.13; 95% CI: 0.99–1.30) or dementia (HR: 1.20; 95% CI: 0.92–1.57). Additionally, we did not observe significant additive interaction between the dichotomous subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score for any cognitive impairment (RERI: −0.02; 95% CI: −0.31–0.27), CIND (RERI: −0.03; 95% CI: −0.32–0.27), or dementia (RERI: 0.01; 95% CI: −0.61–0.63) (S3 Table).

African ancestries sample

Multivariable analysis.

We observed that a one standard deviation increase in the subjective neighborhood disadvantage index was associated with a 5% higher risk of any cognitive impairment (95% CI: 0.94–1.17), a 4% higher risk of CIND (95% CI: 0.93–1.17), and a 3% higher risk of dementia (95% CI: 0.90–1.20) in the fully adjusted model; however, these associations were not statistically significant (Table 2). We found no evidence of multiplicative interaction between the subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score; however, power to detect small-to-moderate effects was limited.

RERI analysis.

Similarly, in the RERI models with dichotomized exposures, living in the more disadvantaged neighborhoods was associated with higher risk of developing cognitive impairment, while the association was not significant (S2 Table). In addition, we found no evidence of additive interaction between the subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score for any cognitive impairment, CIND, or dementia in the African ancestries sample where power to detect an interaction was limited. (S3 Table).

Sensitivity analysis

To test the robustness of our models, we added several sensitivity covariates including smoking, alcohol consumption, BMI, diabetes, self-rated hearing, self-rated vision, brain-related conditions, chronic conditions, and depression (S4 Table). After adjustment for sensitivity variables, the associations between subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score with the risk of any cognitive impairment and dementia remained robust in the European ancestries sample (S4 Table), however, the association became non-significant in the CIND European ancestries sample (HR: 1.05; 95% CI: 1.00–1.11). Both multiplicative and additive interaction effects between the polygenic score for Alzheimer’s disease and subjective neighborhood disadvantage index were non-significant (Table 2 and S3 Table). In addition, all main and interaction effects of subjective neighborhood disadvantage index and Alzheimer’s disease polygenic score remained non-significant in the African ancestries sample (Table 2 and S3 Table).

To examine each dimension of neighborhood, we tested each neighborhood factor separately. In the European ancestries samples, when accounting for age, gender, education, poverty, APOE-ε4, subjective social status, and genetic principal components in Cox models; neighborhood safety, trust, friendliness, cleanliness, vandalism, and belonging were all individually associated with higher risk of any cognitive impairment, CIND, and dementia in the European ancestries sample (S5 Table). Only neighborhood friendliness was significantly associated with risk of any cognitive impairment and CIND in the African ancestries sample (S5 Table).

Discussion

Using data from a population-based, longitudinal study of older adults in the United States, we found that living in a more disadvantaged neighborhood was associated with a higher risk of developing incident cognitive impairment in European ancestries. Further, the Alzheimer’s disease polygenic score was associated with cognitive impairment in individuals of European ancestries. However, we found no evidence of effect modification between the Alzheimer’s disease polygenic score and subjective neighborhood disadvantage index on cognitive impairment, whether evaluated on the multiplicative or additive scale, though power to detect small-to-moderate effects, particularly in the African ancestries, was limited. Our results suggest that neighborhood characteristics influence cognitive impairment risk independent of genetic predisposition - Alzheimer’s disease polygenic score. These findings underscore the significant role of neighborhood factors in cognitive impairment and highlight the need for examining targeted interventions in disadvantaged communities to potentially mitigate cognitive decline.

European ancestries findings and consistency

We observed that perceived neighborhood disadvantage (higher subjective neighborhood disadvantage index) was associated with an increased risk of cognitive impairment in the European ancestries sample. This finding aligns with existing literature. For example, a population-based cross-sectional study of 10,289 middle-aged and older adults indicated that a perceived traffic issue and lack of adequate parks were linked to worse cognitive function [56]. In the National Social Life, Health, and Aging Project, higher levels of perceived neighborhood danger (1 mile radius from the home, or within a 20 minute walk of the home) were associated with lower cognitive function, while residents of more cohesive neighborhoods exhibited better cognitive performance [10]. Similarly, a community-level study conducted in Korea with 1,974,944 participants over 50 years of age found that higher community-level social trust is associated with a reduced risk of dementia [13]. In sensitivity analyses where each perceived neighborhood characteristic was considered individually, neighborhood safety, cleanliness, trust, cleanliness, vandalism and belonging were significantly associated with the risk of cognitive impairment in the European ancestries sample. This indicates that both perceived neighborhood environment and neighborhood connections are crucial risk factors for cognitive health.

African ancestries findings and consistency

The association between subjective neighborhood disadvantage index and cognitive impairment was also observed in African ancestries participants, but the estimate may be imprecise, with a 95% confidence interval crossing the null. We did note a significant association between higher perceived neighborhood friendliness and the lower risk of cognitive impairment in the African ancestries participants. Existing studies indicate that, despite the significant growth of the middle-class Black Americans in the United States, many continue to live in inferior neighborhoods compared to white counterparts [5759]. This suggests that even with rising income levels, African ancestry communities still encounter structural inequalities that limit their access to better housing and living environments. Furthermore, these inequalities extend beyond housing to areas like education, employment, and healthcare, affecting the overall health of minority populations [60]. Neighborhood friendliness and social support, while not the only factor, could play a critical role in mitigating the stressors that contribute to cognitive impairment in African ancestry population [61]. Additionally, the nature of the HRS may introduce selective survival bias, as those experiencing a higher disease burden are less likely to be included or remain in the study [62], potentially underestimating the impact of disadvantaged neighborhoods on cognitive impairment, biasing results towards the null. This issue maybe more pronounced among racial minority groups, who are disproportionately affected by cumulative disadvantage, chronic disease, and premature mortality compared to Non-Hispanic White populations [63,64].

Neighborhood characteristics

We utilized a subjective neighborhood disadvantage index derived through principal component analysis to present neighborhood characteristics. While this approach reduces dimensionality by integrating correlated variables into a composite measure, it may not fully capture the variability across neighborhood characteristics. To address this limitation, we conducted sensitivity analyses by examining each neighborhood characteristic individually, providing a more nuanced perspective. Additionally, the index included only seven dimensions of subjective neighborhood characteristics, which may not comprehensively reflect the range of relevant factors. Future research should incorporate additional variables, such as walkability, aesthetic appeal, and neighborhood diversity, to achieve a more complete assessment. Furthermore, we measured neighborhood factors and covariates only at baseline. Although neighborhood characteristics tend to be relatively stable – especially in this sample, the results would be more precise and dynamic if neighborhood factors were included as time-varying variables in future analyses. Our focus on subjective neighborhood characteristics is a strength, as these measures capture direct mental and emotional responses to the environment. Nevertheless, future research should also incorporate objective neighborhood measures to complement and validate our findings.

Genetic factors

We found the association between the Alzheimer’s disease polygenic score and cognitive impairment only among the European ancestries participants. Although previous studies have identified significant associations between the Alzheimer’s disease polygenic score and cognitive impairment in both European and African ancestries populations [6567], some findings suggest that these associations may depend on the inclusion of the APOE locus [6871]. We observed a significant association between APOE-ε4 status and cognitive impairment in both European and African ancestries samples. This is consistent with another study, which found that participants with any APOE-ε4 allele had 2.42 times higher odds of developing dementia in European ancestry samples and 1.77 times higher odds in African ancestry samples compared to those without the allele [72]. The robust association of APOE-ε4 with cognitive impairment across diverse populations reinforces its role as a significant genetic risk factor for Alzheimer’s disease and related cognitive declines [73]. Moreover, while the limited sample size of African ancestry participants may reduce the statistical power to detect significant associations, additional factors related to ancestry-specific polygenic risk scores also warrant consideration. Specifically, the polygenic risk scores used in this analysis were derived from GWASs primarily conducted in European ancestry populations [74]. Such GWASs often have limited transferability to non-European populations due to differences in linkage disequilibrium, minor allele frequency, heritability, and genetic correlation across ancestries [74]. Additionally, the included analytic European ancestries sample had a lower Alzheimer’s disease polygenic score than the excluded sample due to missingness of covariates. This pattern raises the possibility of selection bias, which could potentially lead to underestimation of the true association between the Alzheimer’s disease polygenic score and cognitive impairment in the European ancestries.

Strengths

Our study stratified by ancestries, allowing for the examination of interactions between genetic and neighborhood factors within specific population subgroups. Secondly, we employed longitudinal cognitive assessments to evaluate the risk of developing cognitive impairment over time which is a strength compared to cross-sectional studies. Additionally, we incorporated subjective measurements of neighborhood factors across seven dimensions: vandalism, cleanliness, vacancies, trust, belonging, friendliness, and safety. This detailed exploration enables a nuanced understanding of how various neighborhood aspects contribute to cognitive health outcomes over time.

Conclusions

Our study investigated the relationship between seven subjective neighborhood characteristics—both collectively and individually—and genetic factors on the risk of cognitive impairment. We found that living in a more disadvantaged neighborhood and having a higher genetic risk for Alzheimer’s disease were significantly associated with an increased risk of developing any cognitive impairment, CIND, and dementia among European ancestries participants. However, the association of neighborhood characteristics on cognitive impairment risk did not vary based on genetic risk for Alzheimer’s disease. Given the evidence provided from this study and previous literature, we suggest that neighborhood is an important modifiable risk factor for cognitive health. Public health interventions should prioritize improving neighborhood safety, cleanliness, and fostering community connections (trust, friendliness and belonging), as these factors are significantly associated with the risk of cognitive impairment. Future research should incorporate longitudinal assessments of neighborhood characteristics to enhance the robustness of findings.

Supporting information

S1 Table. Characteristics of included and excluded participants with neighborhood disadvantage index in the Health and Retirement Study (2008–2010 Waves).

an (%); Mean (SD). bPearson’s Chi-squared test; Welch Two Sample t-test.

(DOCX)

pone.0336403.s001.docx (44.2KB, docx)
S2 Table. Sample distribution by genetic ancestry in the Health and Retirement Study, wave 2008–2010.

an (%); Mean (SD).

(DOCX)

pone.0336403.s002.docx (36.5KB, docx)
S3 Table. Hazard ratios from survival analysis with binary neighborhood disadvantage index stratified by ancestry, estimates present the association for the most disadvantaged neighborhoods with incident cognitive impairment (CIND and dementia), CIND and dementia, relative to normal cognition and non-dementia respectively in the US Health and Retirement Study (2008–2010 Waves).

(DOCX)

pone.0336403.s003.docx (47.8KB, docx)
S4 Table. Hazard ratios from survival analysis with additional sensitivity covariates stratified by ancestry, estimates present the association for each standard deviation increase in the neighborhood disadvantage index with incident cognitive impairment (CIND and dementia), CIND and dementia, relative to normal cognition and non-dementia respectively in the US Health and Retirement Study (2008–2010 Waves).

Each model further adjusted for Smoking, Alcohol Consumption, BMI, Diabetes, Self-Rated Hearing and Vision, Brain-related Conditions, Chronic Conditions, and Depression.

(DOCX)

pone.0336403.s004.docx (75.2KB, docx)
S5 Table. Hazard ratios from survival analysis using individual neighborhood factor as exposure, stratified by ancestry: risk of incident cognitive impairment (CIND and dementia), CIND and dementia, relative to normal cognition and non-dementia in the US Health and Retirement Study (2008–2010 Waves).

All models adjusted for Age, Sex, Education, Poverty Status, APOE E4 Status, Social Ladder, and Baseline Wave.

(DOCX)

pone.0336403.s005.docx (45.4KB, docx)
S6 Table. Hazard ratios from survival analysis comparing binary neighborhood disadvantage index with additional covariates, stratified by ancestry: risk of incident cognitive impairment (CIND and dementia), CIND and dementia in the US Health and Retirement Study (2008–2010 Waves).

(DOCX)

pone.0336403.s006.docx (94.1KB, docx)

Acknowledgments

We thank the participants and staff of the Health and Retirement Study.

Abbreviations

CI

confidence interval

SD

standard deviation

SNPs

single-nucleotide polymorphisms

GWAS

genome wide association study

BMI

body mass index

APOE

Apolipoprotein E.

Data Availability

This analysis uses data from the Health and Retirement Study, polygenic scores, leave-behind questionnaire, Imputation of Cognitive Functioning Measures, and core study, sponsored by the National Institute on Aging (grant number NIA U01AG009740) and conducted by the University of Michigan. The data that support the findings of this study are publicly available at https://hrs.isr.umich.edu/.

Funding Statement

This work was supported by the National Institute on Aging (NIA): EBW (Erin B. Ware): R01 AG055406. KMB (Kelly M. Bakulski): R01 AG067592, P30 AG072931. GAN (Grace A. Noppert): R01 AG075719. LCK (Lindsay C. Kobayashi): R01 AG070953.

References

  • 1.Nowrangi MA, Rao V, Lyketsos CG. Epidemiology, assessment, and treatment of dementia. Psychiatr Clin North Am. 2011;34(2):275–94, vii. doi: 10.1016/j.psc.2011.02.004 [DOI] [PubMed] [Google Scholar]
  • 2.Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600–8. doi: 10.1016/j.arcmed.2012.11.003 [DOI] [PubMed] [Google Scholar]
  • 3.Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D, et al. Racial and ethnic estimates of Alzheimer’s disease and related dementi as in the United States (2015–2060) in adults aged ≥65 years. Alzheimer Dementia. 2019;15(1):17–24. doi: 10.1016/j.jalz.2018.06.3063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Skaria AP. The economic and societal burden of Alzheimer disease: managed care considerations. Am J Manag Care. 2022;28(10 Suppl):S188–96. doi: 10.37765/ajmc.2022.89236 [DOI] [PubMed] [Google Scholar]
  • 5.Hugo J, Ganguli M. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med. 2014;30(3):421–42. doi: 10.1016/j.cger.2014.04.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Morris JC. Mild cognitive impairment and preclinical Alzheimer’s disease. Geriatrics. 2005;Suppl:9–14. [PubMed] [Google Scholar]
  • 7.Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L-O, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240–6. doi: 10.1111/j.1365-2796.2004.01380.x [DOI] [PubMed] [Google Scholar]
  • 8.Letellier N, Gutierrez L-A, Carrière I, Gabelle A, Dartigues J-F, Dufouil C, et al. Sex-specific association between neighborhood characteristics and dementia: The Three-City cohort. Alzheimers Dement. 2018;14(4):473–82. doi: 10.1016/j.jalz.2017.09.015 [DOI] [PubMed] [Google Scholar]
  • 9.Slawsky ED, Hajat A, Rhew IC, Russette H, Semmens EO, Kaufman JD, et al. Neighborhood greenspace exposure as a protective factor in dementia risk among U.S. adults 75 years or older: a cohort study. Environ Health. 2022;21(1):14. doi: 10.1186/s12940-022-00830-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lee H, Waite LJ. Cognition in Context: The Role of Objective and Subjective Measures of Neighborhood and Household in Cognitive Functioning in Later Life. Gerontologist. 2018;58(1):159–69. doi: 10.1093/geront/gnx050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Whitley E, Olsen J, Benzeval M. Impact of subjective and objective neighbourhood characteristics and individual socioeconomic position on allostatic load: A cross-sectional analysis of an all-age UK household panel study. Health Place. 2022;78:102930. doi: 10.1016/j.healthplace.2022.102930 [DOI] [PubMed] [Google Scholar]
  • 12.Guo Y, Chan CH, Chang Q, Liu T, Yip PSF. Neighborhood environment and cognitive function in older adults: A multilevel analysis in Hong Kong. Health Place. 2019;58:102146. doi: 10.1016/j.healthplace.2019.102146 [DOI] [PubMed] [Google Scholar]
  • 13.Hong J, Park SJ, Lee J-K, Jeong HJ, Oh J, Choi S, et al. Association between community-level social trust and the risk of dementia: A retrospective cohort study in the Republic of Korea. Front Public Health. 2022;10:913319. doi: 10.3389/fpubh.2022.913319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Muñoz E, Scott SB, Corley R, Wadsworth SJ, Sliwinski MJ, Reynolds CA. The role of neighborhood stressors on cognitive function: A coordinated analysis. Health Place. 2020;66:102442. doi: 10.1016/j.healthplace.2020.102442 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Robinette JW, Piazza JR, Stawski RS. Neighborhood safety concerns and daily well-being: A national diary study. Wellbeing Space Soc. 2021;2:100047. doi: 10.1016/j.wss.2021.100047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Tucker-Seeley RD, Subramanian SV, Li Y, Sorensen G. Neighborhood safety, socioeconomic status, and physical activity in older adults. Am J Prev Med. 2009;37(3):207–13. doi: 10.1016/j.amepre.2009.06.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Breedvelt JJF, Tiemeier H, Sharples E, Galea S, Niedzwiedz C, Elliott I, et al. The effects of neighbourhood social cohesion on preventing depression and anxiety among adolescents and young adults: rapid review. BJPsych Open. 2022;8(4):e97. doi: 10.1192/bjo.2022.57 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Seifert A. Day-to-Day Contact and Help Among Neighbors Measured in the Natural Environment. Innov Aging. 2020;4(2):igaa009. doi: 10.1093/geroni/igaa009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Iso-Markku P, Aaltonen S, Kujala UM, Halme H-L, Phipps D, Knittle K, et al. Physical Activity and Cognitive Decline Among Older Adults: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024;7(2):e2354285. doi: 10.1001/jamanetworkopen.2023.54285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kulshreshtha A, Alonso A, McClure LA, Hajjar I, Manly JJ, Judd S. Association of Stress With Cognitive Function Among Older Black and White US Adults. JAMA Netw Open. 2023;6(3):e231860. doi: 10.1001/jamanetworkopen.2023.1860 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Yu X, Westrick AC, Kobayashi LC. Cumulative loneliness and subsequent memory function and rate of decline among adults aged ≥50 in the United States, 1996 to 2016. Alzheimers Dement. 2023;19(2):578–88. doi: 10.1002/alz.12734 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fan J, Tao W, Li X, Li H, Zhang J, Wei D, et al. The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk. Int J Mol Sci. 2019;20(5):1177. doi: 10.3390/ijms20051177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sapkota S, Dixon RA. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer’s Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers. J Alzheimers Dis. 2018;62(2):887–900. doi: 10.3233/JAD-170909 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Carmona S, Hardy J, Guerreiro R. The genetic landscape of Alzheimer disease. Handb Clin Neurol. 2018;148:395–408. doi: 10.1016/B978-0-444-64076-5.00026-0 [DOI] [PubMed] [Google Scholar]
  • 25.Smith JA, Kho M, Zhao W, Yu M, Mitchell C, Faul JD. Genetic effects and gene-by-education interactions on episodic memory performance and decline in an aging population. Soc Sci Med. 2021;271:112039. doi: 10.1016/j.socscimed.2018.11.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kraft P, Aschard H. Finding the missing gene-environment interactions. Eur J Epidemiol. 2015;30(5):353–5. doi: 10.1007/s10654-015-0046-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Luck T, Riedel-Heller SG, Luppa M, Wiese B, Köhler M, Jessen F, et al. Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: analysis of gene-environment interaction for the risk of dementia and Alzheimer’s disease dementia. Psychol Med. 2014;44(6):1319–29. doi: 10.1017/S0033291713001918 [DOI] [PubMed] [Google Scholar]
  • 28.Lau M, Kress S, Schikowski T, Schwender H. Efficient gene-environment interaction testing through bootstrap aggregating. Sci Rep. 2023;13(1):937. doi: 10.1038/s41598-023-28172-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nakamura S, Narimatsu H, Sato H, Sho R, Otani K, Kawasaki R, et al. Gene-environment interactions in obesity: implication for future applications in preventive medicine. J Hum Genet. 2016;61(4):317–22. doi: 10.1038/jhg.2015.148 [DOI] [PubMed] [Google Scholar]
  • 30.Juster FT, Suzman R. An Overview of the Health and Retirement Study. J Human Res. 1995;30:S7. doi: 10.2307/146277 [DOI] [Google Scholar]
  • 31.Sonnega A, Faul JD, Ofstedal MB, Langa KM, Phillips JWR, Weir DR. Cohort Profile: the Health and Retirement Study (HRS). Int J Epidemiol. 2014;43(2):576–85. doi: 10.1093/ije/dyu067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Maćkiewicz A, Ratajczak W. Principal components analysis (PCA). Comput Geosci. 1993;19(3):303–42. doi: 10.1016/0098-3004(93)90090-r [DOI] [Google Scholar]
  • 33.Wallace R, Herzog AR, Weir DR, Ofstedal MB, Langa KM, Fisher GG, et al. Documentation of Cognitive Functioning Measures in the Health and Ret irement Study. Survey Research Center. 2005. Report No.
  • 34.McCammon RJ, Fisher GG, Hassan H, Faul JD, Rodgers WL, Weir DR. Health and Retirement Study Imputation of Cognitive Functioning Measures: 1992 – 2020. Ann Arbor, MI. 2023. [Google Scholar]
  • 35.Crimmins EM, Kim JK, Langa KM, Weir DR. Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci. 2011;66(Suppl 1):i162-71. doi: 10.1093/geronb/gbr048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006;2(12):e190. doi: 10.1371/journal.pgen.0020190 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904–9. doi: 10.1038/ng1847 [DOI] [PubMed] [Google Scholar]
  • 38.Weir D. Quality Control Report for Genotypic Data. 2013.
  • 39.Ware E, Gard A, Schmitz L, Faul J. HRS Polygenic Scores – Release 4.3 2006-2012 Genetic Data. Survey Research Center. 2021. Report No.
  • 40.Sugrue LP, Desikan RS. What Are Polygenic Scores and Why Are They Important? JAMA. 2019;321(18):1820–1. doi: 10.1001/jama.2019.3893 [DOI] [PubMed] [Google Scholar]
  • 41.Alzheimer Disease Genetics C, The European Alzheimer’s Disease I, Cohorts for H, Aging Research in Genomic Epidemiology Consortiu m, Genetic, Environmental Risk in Ad/Defining Genetic P, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 2019;51(3):414–30. doi: 10.1038/s41588-019-0358-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Ware EB, Faul JD, Mitchell CM, Bakulski KM. Considering the APOE locus in polygenic scores for Alzheimer’s disease. 2019. doi: 10.1101/2019.12.10.19014365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lee YC, Jung S-H, Shivakumar M, Cha S, Park W-Y, Won H-H, et al. Polygenic risk score-based phenome-wide association study of head and neck cancer across two large biobanks. BMC Med. 2024;22(1):120. doi: 10.1186/s12916-024-03305-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Hale JM, Schneider DC, Mehta NK, Myrskylä M. Cognitive impairment in the U.S.: Lifetime risk, age at onset, and years impaired. SSM Popul Health. 2020;11:100577. doi: 10.1016/j.ssmph.2020.100577 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wang A-Y, Hu H-Y, Ou Y-N, Wang Z-T, Ma Y-H, Tan L, et al. Socioeconomic Status and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 39 Prospective Studies. J Prev Alzheimers Dis. 2023;10(1):83–94. doi: 10.14283/jpad.2022.81 [DOI] [PubMed] [Google Scholar]
  • 46.Adler NE, Epel ES, Castellazzo G, Ickovics JR. Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women. Health Psychol. 2000;19(6):586–92. doi: 10.1037//0278-6133.19.6.586 [DOI] [PubMed] [Google Scholar]
  • 47.Gutwinski S, Schreiter S, Priller J, Henssler J, Wiers CE, Heinz A. Drink and Think: Impact of Alcohol on Cognitive Functions and Dementia - Evidence of Dose-Related Effects. Pharmacopsychiatry. 2018;51(4):136–43. doi: 10.1055/s-0043-118664 [DOI] [PubMed] [Google Scholar]
  • 48.Kim J, Park E, An M. The Cognitive Impact of Chronic Diseases on Functional Capacity in Community-Dwelling Adults. J Nurs Res. 2019;27(1):1–8. doi: 10.1097/jnr.0000000000000272 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ohara T, Ninomiya T, Hata J, Ozawa M, Yoshida D, Mukai N, et al. Midlife and Late-Life Smoking and Risk of Dementia in the Community: The Hisayama Study. J Am Geriatr Soc. 2015;63(11):2332–9. doi: 10.1111/jgs.13794 [DOI] [PubMed] [Google Scholar]
  • 50.Qizilbash N, Gregson J, Johnson ME, Pearce N, Douglas I, Wing K, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. 2015;3(6):431–6. doi: 10.1016/S2213-8587(15)00033-9 [DOI] [PubMed] [Google Scholar]
  • 51.Blot WJ, Day NE. Synergism and interaction: are they equivalent? Am J Epidemiol. 1979;110(1):99–100. doi: 10.1093/oxfordjournals.aje.a112793 [DOI] [PubMed] [Google Scholar]
  • 52.VanderWeele TJ, Knol MJ. A Tutorial on Interaction. Epidemiol Method. 2014;3(1). doi: 10.1515/em-2013-0005 [DOI] [Google Scholar]
  • 53.Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17(3):227–36. doi: 10.1016/j.annepidem.2006.10.009 [DOI] [PubMed] [Google Scholar]
  • 54.Stevenson M, Sergeant E. epiR: Tools for the Analysis of Epidemiological Data. 2008. [Google Scholar]
  • 55.Knol MJ, VanderWeele TJ, Groenwold RHH, Klungel OH, Rovers MM, Grobbee DE. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol. 2011;26(6):433–8. doi: 10.1007/s10654-011-9554-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sylvers DL, Hicken M, Esposito M, Manly J, Judd S, Clarke P. Walkable Neighborhoods and Cognition: Implications for the Design of Health Promoting Communities. J Aging Health. 2022;34(6–8):893–904. doi: 10.1177/08982643221075509 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Egede LE, Walker RJ, Campbell JA, Linde S, Hawks LC, Burgess KM. Modern Day Consequences of Historic Redlining: Finding a Path Forward. J Gen Intern Med. 2023;38(6):1534–7. doi: 10.1007/s11606-023-08051-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Hobson-Prater T, Leech TGJ. The Significance of Race for Neighborhood Social Cohesion: Perceived Difficulty of Collective Action in Majority Black Neighborhoods. J Sociol Social Welfare. 2012;39(1). doi: 10.15453/0191-5096.3651 [DOI] [Google Scholar]
  • 59.Sampson RJ, Morenoff JD, Gannon-Rowley T. Assessing “Neighborhood Effects”: Social Processes and New Directions in Research. Annu Rev Sociol. 2002;28(1):443–78. doi: 10.1146/annurev.soc.28.110601.141114 [DOI] [Google Scholar]
  • 60.Egede LE, Walker RJ, Williams JS. Addressing Structural Inequalities, Structural Racism, and Social Determinants of Health: a Vision for the Future. J Gen Intern Med. 2024;39(3):487–91. doi: 10.1007/s11606-023-08426-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Choi J, Han SH, Ng YT, Muñoz E. Neighborhood Cohesion Across the Life Course and Effects on Cognitive Aging. J Gerontol B Psychol Sci Soc Sci. 2023;78(10):1765–74. doi: 10.1093/geronb/gbad095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Czeisler MÉ, Wiley JF, Czeisler CA, Rajaratnam SMW, Howard ME. Uncovering survivorship bias in longitudinal mental health surveys during the COVID-19 pandemic. Epidemiol Psychiatr Sci. 2021;30:e45. doi: 10.1017/S204579602100038X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Angel JL, Angel RJ. Minority group status and healthful aging: social structure still matters. Am J Public Health. 2006;96(7):1152–9. doi: 10.2105/AJPH.2006.085530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28–292. doi: 10.1161/01.cir.0000441139.02102.80 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Altmann A, Scelsi MA, Shoai M, de Silva E, Aksman LM, Cash DM, et al. A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE. Brain Commun. 2020;2(1):fcz047. doi: 10.1093/braincomms/fcz047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Axelrud LK, Santoro ML, Pine DS, Talarico F, Gadelha A, Manfro GG, et al. Polygenic Risk Score for Alzheimer’s Disease: Implications for Memory Performance and Hippocampal Volumes in Early Life. Am J Psychiatry. 2018;175(6):555–63. doi: 10.1176/appi.ajp.2017.17050529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, et al. Polygenic risk and hazard scores for Alzheimer’s disease prediction. Ann Clin Transl Neurol. 2019;6(3):456–65. doi: 10.1002/acn3.716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Harris SE, Davies G, Luciano M, Payton A, Fox HC, Haggarty P, et al. Polygenic risk for Alzheimer’s disease is not associated with cognitive ability or cognitive aging in non-demented older people. J Alzheimers Dis. 2014;39(3):565–74. doi: 10.3233/JAD-131058 [DOI] [PubMed] [Google Scholar]
  • 69.Manzali SB, Yu E, Ravona-Springer R, Livny A, Golan S, Ouyang Y, et al. Alzheimer’s Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes. Front Aging Neurosci. 2022;14:853695. doi: 10.3389/fnagi.2022.853695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Marden JR, Mayeda ER, Walter S, Vivot A, Tchetgen Tchetgen EJ, Kawachi I, et al. Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up. Alzheimer Dis Assoc Disorders. 2016;30(3):195–202. doi: 10.1097/wad.0000000000000137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Verhaaren BFJ, Vernooij MW, Koudstaal PJ, Uitterlinden AG, van Duijn CM, Hofman A, et al. Alzheimer’s disease genes and cognition in the nondemented general population. Biol Psychiatry. 2013;73(5):429–34. doi: 10.1016/j.biopsych.2012.04.009 [DOI] [PubMed] [Google Scholar]
  • 72.Bakulski KM, Vadari HS, Faul JD, Heeringa SG, Kardia SLR, Langa KM, et al. Cumulative Genetic Risk and APOE ε4 Are Independently Associated With Dementia Status in a Multiethnic, Population-Based Cohort. Neurol Genet. 2021;7(2):e576. doi: 10.1212/NXG.0000000000000576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55(7):964–8. doi: 10.1001/archneur.55.7.964 [DOI] [PubMed] [Google Scholar]
  • 74.Wang Y, Kanai M, Tan T, Kamariza M, Tsuo K, Yuan K, et al. Polygenic prediction across populations is influenced by ancestry, genetic architecture, and methodology. Cell Genom. 2023;3(10):100408. doi: 10.1016/j.xgen.2023.100408 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mu-Hong Chen

29 Sep 2025

Dear Dr. Ware,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Mu-Hong Chen, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: This is a rigorous and creative analytic approach. It not only focuses on the primary research topic (neighborhood environment) but also simultaneously takes dementia polygenic risk into account.

I only have a few questions to raise:

In the covariates included for the sensitivity analysis, according to The Lancet 2024 dementia risk factor report, the following are missing: hearing impairment, visual impairment, traumatic brain injury, and air pollution.

(I understand there may be design limitations, especially in measuring air pollution, but please at least acknowledge this in the limitations section.)

In addition to the above, I personally believe that substance use and epilepsy should also be considered.

Regarding the categorization of chronic conditions (0, 1–2, ≥3), I think this approach is debatable. I recommend that brain-related conditions (psychiatric disorders, stroke) be separated out, while the remaining physical comorbidities could either be assessed using the CCI score or treated as individual covariates.

Reviewer #2: This cohort study in HRS (2008–2020) examines whether perceived neighborhood disadvantage and Alzheimer’s disease polygenic score (APOE-excluded) predict incident cognitive impairment. In European-ancestry participants, both exposures independently associate with higher risk; no multiplicative or additive interaction is detected. African-ancestry estimates are imprecise. I only have a few comments on this article.

Abstract

1. In the Results, please avoid vague phrases such as “similar effect sizes” and “comparable but nonsignificant trends were noted in the African-ancestry sample”; instead, report the numerical estimates (e.g., HRs with 95% CIs).

Results

2. Given the small African ancestries sample and limited power, the phrasing “comparable but nonsignificant trends” should be tempered to “evidence was inconclusive in African ancestries due to limited precision.”

Discussion

3. Replace any phrasing implying the absence of interaction with language that emphasizes evidence not detected and limited precision, especially for African ancestries: e.g., “We found no evidence of multiplicative or additive interaction; however, power to detect small-to-moderate effects—particularly in African ancestries—was limited.”

4. Avoid “comparable but nonsignificant trends.” Use: “Estimates in African ancestries were directionally similar but imprecise, and the evidence was inconclusive due to limited precision and cross-ancestry PRS transferability.”

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Decision Letter 1

Mu-Hong Chen

26 Oct 2025

Associations of Perceived Neighborhood Factors and Alzheimer’s Disease Polygenic Score with Cognition: Evidence from the Health and Retirement Study

PONE-D-25-46504R1

Dear Dr. Erin B Ware,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mu-Hong Chen, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The author did a good job. All comment had been addressed. I have no further comment. ..............

Reviewer #2: The authors have fully addressed all the questions I raised, and I have no further comments or additional feedback at this time.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Mu-Hong Chen

PONE-D-25-46504R1

PLOS ONE

Dear Dr. Ware,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mu-Hong Chen

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Characteristics of included and excluded participants with neighborhood disadvantage index in the Health and Retirement Study (2008–2010 Waves).

    an (%); Mean (SD). bPearson’s Chi-squared test; Welch Two Sample t-test.

    (DOCX)

    pone.0336403.s001.docx (44.2KB, docx)
    S2 Table. Sample distribution by genetic ancestry in the Health and Retirement Study, wave 2008–2010.

    an (%); Mean (SD).

    (DOCX)

    pone.0336403.s002.docx (36.5KB, docx)
    S3 Table. Hazard ratios from survival analysis with binary neighborhood disadvantage index stratified by ancestry, estimates present the association for the most disadvantaged neighborhoods with incident cognitive impairment (CIND and dementia), CIND and dementia, relative to normal cognition and non-dementia respectively in the US Health and Retirement Study (2008–2010 Waves).

    (DOCX)

    pone.0336403.s003.docx (47.8KB, docx)
    S4 Table. Hazard ratios from survival analysis with additional sensitivity covariates stratified by ancestry, estimates present the association for each standard deviation increase in the neighborhood disadvantage index with incident cognitive impairment (CIND and dementia), CIND and dementia, relative to normal cognition and non-dementia respectively in the US Health and Retirement Study (2008–2010 Waves).

    Each model further adjusted for Smoking, Alcohol Consumption, BMI, Diabetes, Self-Rated Hearing and Vision, Brain-related Conditions, Chronic Conditions, and Depression.

    (DOCX)

    pone.0336403.s004.docx (75.2KB, docx)
    S5 Table. Hazard ratios from survival analysis using individual neighborhood factor as exposure, stratified by ancestry: risk of incident cognitive impairment (CIND and dementia), CIND and dementia, relative to normal cognition and non-dementia in the US Health and Retirement Study (2008–2010 Waves).

    All models adjusted for Age, Sex, Education, Poverty Status, APOE E4 Status, Social Ladder, and Baseline Wave.

    (DOCX)

    pone.0336403.s005.docx (45.4KB, docx)
    S6 Table. Hazard ratios from survival analysis comparing binary neighborhood disadvantage index with additional covariates, stratified by ancestry: risk of incident cognitive impairment (CIND and dementia), CIND and dementia in the US Health and Retirement Study (2008–2010 Waves).

    (DOCX)

    pone.0336403.s006.docx (94.1KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers.docx

    pone.0336403.s007.docx (18.4KB, docx)

    Data Availability Statement

    This analysis uses data from the Health and Retirement Study, polygenic scores, leave-behind questionnaire, Imputation of Cognitive Functioning Measures, and core study, sponsored by the National Institute on Aging (grant number NIA U01AG009740) and conducted by the University of Michigan. The data that support the findings of this study are publicly available at https://hrs.isr.umich.edu/.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES